Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Structural Analysis and Dynamic Processes of the Transmembrane Segment Inside Different Micellar Environments-Implications for the TM4 Fragment of the Bilitranslocase Protein.

Szutkowski K, Sikorska E, Bakanovych I, Choudhury AR, Perdih A, Jurga S, Novič M, Zhukov I.

Int J Mol Sci. 2019 Aug 26;20(17). pii: E4172. doi: 10.3390/ijms20174172.

2.

The in vitro protective effects of the three novel nanomolar reversible inhibitors of human cholinesterases against irreversible inhibition by organophosphorous chemical warfare agents.

Vitorović-Todorović MD, Worek F, Perdih A, Bauk SĐ, Vujatović TB, Cvijetić IN.

Chem Biol Interact. 2019 Aug 25;309:108714. doi: 10.1016/j.cbi.2019.06.027. Epub 2019 Jun 19.

PMID:
31228470
3.

Structure-guided optimization of 4,6-substituted-1,3,5-triazin-2(1H)-ones as catalytic inhibitors of human DNA topoisomerase IIα.

Bergant K, Janežič M, Valjavec K, Sosič I, Pajk S, Štampar M, Žegura B, Gobec S, Filipič M, Perdih A.

Eur J Med Chem. 2019 Aug 1;175:330-348. doi: 10.1016/j.ejmech.2019.04.055. Epub 2019 Apr 25.

PMID:
31096154
4.

Discovery of (phenylureido)piperidinyl benzamides as prospective inhibitors of bacterial autolysin E from Staphylococcus aureus.

Borišek J, Pintar S, Ogrizek M, Grdadolnik SG, Hodnik V, Turk D, Perdih A, Novič M.

J Enzyme Inhib Med Chem. 2018 Dec;33(1):1239-1247. doi: 10.1080/14756366.2018.1493474.

5.

Discovery of Mcl-1 inhibitors from integrated high throughput and virtual screening.

Mady ASA, Liao C, Bajwa N, Kump KJ, Abulwerdi FA, Lev KL, Miao L, Grigsby SM, Perdih A, Stuckey JA, Du Y, Fu H, Nikolovska-Coleska Z.

Sci Rep. 2018 Jul 5;8(1):10210. doi: 10.1038/s41598-018-27899-9.

6.

In Silico Discovery of a Substituted 6-Methoxy-quinalidine with Leishmanicidal Activity in Leishmania infantum.

Stevanović S, Perdih A, Senćanski M, Glišić S, Duarte M, Tomás AM, Sena FV, Sousa FM, Pereira MM, Solmajer T.

Molecules. 2018 Mar 27;23(4). pii: E772. doi: 10.3390/molecules23040772.

7.

Bioassays and In Silico Methods in the Identification of Human DNA Topoisomerase IIα Inhibitors.

Bergant K, Janezic M, Perdih A.

Curr Med Chem. 2018;25(28):3286-3318. doi: 10.2174/0929867325666180306165725. Review.

PMID:
29508675
8.

The CWB2 Cell Wall-Anchoring Module Is Revealed by the Crystal Structures of the Clostridium difficile Cell Wall Proteins Cwp8 and Cwp6.

Usenik A, Renko M, Mihelič M, Lindič N, Borišek J, Perdih A, Pretnar G, Müller U, Turk D.

Structure. 2017 Mar 7;25(3):514-521. doi: 10.1016/j.str.2016.12.018. Epub 2017 Jan 26.

9.

Development of a one-pot assay for screening and identification of Mur pathway inhibitors in Mycobacterium tuberculosis.

Eniyan K, Kumar A, Rayasam GV, Perdih A, Bajpai U.

Sci Rep. 2016 Oct 13;6:35134. doi: 10.1038/srep35134.

10.

In Silico Discovery of Novel Potent Antioxidants on the Basis of Pulvinic Acid and Coumarine Derivatives and Their Experimental Evaluation.

Martinčič R, Mravljak J, Švajger U, Perdih A, Anderluh M, Novič M.

PLoS One. 2015 Oct 16;10(10):e0140602. doi: 10.1371/journal.pone.0140602. eCollection 2015.

11.

From carbohydrates to drug-like fragments: Rational development of novel α-amylase inhibitors.

Al-Asri J, Fazekas E, Lehoczki G, Perdih A, Görick C, Melzig MF, Gyémánt G, Wolber G, Mortier J.

Bioorg Med Chem. 2015 Oct 15;23(20):6725-32. doi: 10.1016/j.bmc.2015.09.007. Epub 2015 Sep 8.

PMID:
26395057
12.

4,6-Substituted-1,3,5-triazin-2(1H)-ones as monocyclic catalytic inhibitors of human DNA topoisomerase IIα targeting the ATP binding site.

Pogorelčnik B, Janežič M, Sosič I, Gobec S, Solmajer T, Perdih A.

Bioorg Med Chem. 2015 Aug 1;23(15):4218-29. doi: 10.1016/j.bmc.2015.06.049. Epub 2015 Jul 2.

PMID:
26183545
13.

Furan-based benzene mono- and dicarboxylic acid derivatives as multiple inhibitors of the bacterial Mur ligases (MurC-MurF): experimental and computational characterization.

Perdih A, Hrast M, Pureber K, Barreteau H, Grdadolnik SG, Kocjan D, Gobec S, Solmajer T, Wolber G.

J Comput Aided Mol Des. 2015 Jun;29(6):541-60. doi: 10.1007/s10822-015-9843-6. Epub 2015 Apr 8.

PMID:
25851408
14.

Discovery of mono- and disubstituted 1H-pyrazolo[3,4]pyrimidines and 9H-purines as catalytic inhibitors of human DNA topoisomerase IIα.

Pogorelčnik B, Brvar M, Žegura B, Filipič M, Solmajer T, Perdih A.

ChemMedChem. 2015 Feb;10(2):345-59. doi: 10.1002/cmdc.201402459. Epub 2014 Dec 17.

PMID:
25522133
15.

Monocyclic 4-amino-6-(phenylamino)-1,3,5-triazines as inhibitors of human DNA topoisomerase IIα.

Pogorelčnik B, Brvar M, Zajc I, Filipič M, Solmajer T, Perdih A.

Bioorg Med Chem Lett. 2014 Dec 15;24(24):5762-5768. doi: 10.1016/j.bmcl.2014.10.042. Epub 2014 Oct 22.

PMID:
25453816
16.

Benzene-1,3-dicarboxylic acid 2,5-dimethylpyrrole derivatives as multiple inhibitors of bacterial Mur ligases (MurC-MurF).

Perdih A, Hrast M, Barreteau H, Gobec S, Wolber G, Solmajer T.

Bioorg Med Chem. 2014 Aug 1;22(15):4124-34. doi: 10.1016/j.bmc.2014.05.058. Epub 2014 Jun 2.

PMID:
24953950
17.

Inhibitor design strategy based on an enzyme structural flexibility: a case of bacterial MurD ligase.

Perdih A, Hrast M, Barreteau H, Gobec S, Wolber G, Solmajer T.

J Chem Inf Model. 2014 May 27;54(5):1451-66. doi: 10.1021/ci500104m. Epub 2014 Apr 28.

PMID:
24724969
18.

Molecular dynamics simulation and linear interaction energy study of D-Glu-based inhibitors of the MurD ligase.

Perdih A, Wolber G, Solmajer T.

J Comput Aided Mol Des. 2013 Aug;27(8):723-38. doi: 10.1007/s10822-013-9673-3. Epub 2013 Aug 30.

PMID:
23990043
19.

Discovery of the first inhibitors of bacterial enzyme D-aspartate ligase from Enterococcus faecium (Aslfm).

Škedelj V, Perdih A, Brvar M, Kroflič A, Dubbée V, Savage V, O'Neill AJ, Solmajer T, Bešter-Rogač M, Blanot D, Hugonnet JE, Magnet S, Arthur M, Mainardi JL, Stojan J, Zega A.

Eur J Med Chem. 2013 Sep;67:208-20. doi: 10.1016/j.ejmech.2013.06.017. Epub 2013 Jun 28.

PMID:
23867605
20.

Structural elucidation of transmembrane transporter protein bilitranslocase: conformational analysis of the second transmembrane region TM2 by molecular dynamics and NMR spectroscopy.

Roy Choudhury A, Perdih A, Zuperl S, Sikorska E, Solmajer T, Jurga S, Zhukov I, Novič M.

Biochim Biophys Acta. 2013 Nov;1828(11):2609-19. doi: 10.1016/j.bbamem.2013.06.006. Epub 2013 Jun 15.

Supplemental Content

Loading ...
Support Center